[go: up one dir, main page]

Shahbazy et al., 2015 - Google Patents

Rapid and non-invasive diagnosis of coronary artery disease via clinical laboratory parameters and 1 H-NMR spectra of human blood plasma

Shahbazy et al., 2015

View PDF
Document ID
6306182026537082386
Author
Shahbazy M
Zahraei A
Vafaeimanesh J
Kompany-Zareh M
Publication year
Publication venue
RSC Advances

External Links

Snippet

Coronary artery disease (CAD), one of the most common fatal diseases in the world, was examined in the present study via the investigation of the 1H-NMR spectra of human blood plasma and clinical laboratory parameters, with the aim of early disease diagnosis. Partial …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light

Similar Documents

Publication Publication Date Title
Vignoli et al. Serum or plasma (and which plasma), that is the question
Ala-Korpela Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics
Seyhan et al. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease
Sawant et al. Neutrophil to lymphocyte ratio predicts short-and long-term mortality following revascularization therapy for ST elevation myocardial infarction
Gasparri et al. Diagnostic biomarkers for lung cancer prevention
WO2013016700A1 (en) Methods for generating predictive models for epithelial ovarian cancer and methods for identifying eoc
Sevuk et al. Value of serial platelet indices measurements for the prediction of pulmonary embolism in patients with deep venous thrombosis
CN112881547A (en) Screening method of early liver cancer diagnosis marker for liver cirrhosis and hepatitis population
JP2019148594A (en) Blood condition analysis device, blood condition analysis system, blood condition analysis method and program
Maltesen et al. A longitudinal serum NMR-based metabolomics dataset of ischemia-reperfusion injury in adult cardiac surgery
Wang et al. Predictive value of red blood cell distribution width in chronic obstructive pulmonary disease patients with pulmonary embolism
Lee et al. Metabolomics study in severe extracranial carotid artery stenosis
Liu et al. Identification of novel candidate biomarkers for acute myocardial infarction by the Olink proteomics platform
CN119534858A (en) Coronary microvascular disease-related biomarkers and their applications
Li et al. Analysis of urinary metabolomic profiling for unstable angina pectoris disease based on nuclear magnetic resonance spectroscopy
Shahbazy et al. Rapid and non-invasive diagnosis of coronary artery disease via clinical laboratory parameters and 1 H-NMR spectra of human blood plasma
Horne et al. Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality
Vignoli et al. Metabolomics fingerprint predicts risk of death in dilated cardiomyopathy and heart failure
CN113539478B (en) Metabolic omics-based deep vein thrombosis prediction model establishing method
Lin et al. [Retracted] Study of the Significance of Thromboelastography Changes in Patients with Dyslipidemia
Zhou et al. VLDL and LDL Subfractions Enhance the Risk Stratification of Individuals Who Underwent Epstein–Barr Virus‐Based Screening for Nasopharyngeal Carcinoma: A Multicenter Cohort Study
US20240044826A1 (en) Metabolic vulnerability analyzed by nmr
He et al. [Retracted] The Diagnostic Value of Serum GDF15 and hs‐CTnT in Elderly Patients with Acute Myocardial Infarction
Yu et al. Leukemia can be Effectively Early Predicted in Routine Physical Examination with the Assistance of Machine Learning Models
Tursunaliyeva METHODS OF DETECTION AND DIAGNOSTIC OF DISEASES IN CLINICAL BLOOD ANALYSIS